On June 3 FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
FDA released four guidance documents June 3 detailing responsibilities under the Drug Supply Chain Security Act for pharmaceutical manufacturers, repackagers and other “trading partners” under the 2013 law. Two final guidances provide more detail on how trading partners should identify suspect products and notify others in the support chain, as well as on product identifiers required on packaging under DSCSA.
On June 2 FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
FDA has issued its weekly Enforcement Report for June 2, listing the status of recalls and field corrections for food, cosmetics, tobacco products, drugs, biologics and devices. The report covers both domestic and foreign firms.
On June 1 FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On May 28 FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
FDA has issued its weekly Enforcement Report for May 26, listing the status of recalls and field corrections for food, cosmetics, tobacco products, drugs, biologics and devices. The report covers both domestic and foreign firms.
On May 27 FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On May 26 FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On May 25 FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of: